The company said Monday that it will provide a $119.5 million investment in Truveta's Series C financing round and help launch the company's Truveta Genome Project, which will extend Regeneron's ...
The discrepancy in HPV screening rates emphasizes a need for gender affirming options for sample collections. Considering the susceptibility and infection rate of transmasculine individuals and ...